By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


Company News
RXi Pharma (RXII) Reports Second Quarter 2017 Financial Results And Recent Corporate Highlights 8/10/2017 1:44:15 PM
RXi Pharma (RXII) Enters Into Common Stock Purchase Agreement For Up To $15.0 Million 8/9/2017 7:35:18 AM
RXi Pharma (RXII) Advances Immuno-Oncology Pipeline By Selecting Two sd-rxRNA Compounds For Preclinical Development And Sourcing cGMP Manufacturing 8/8/2017 7:54:30 AM
RXi Pharma (RXII) To Webcast Second Quarter 2017 Financial Results On Thursday, August 10, 2017 8/3/2017 12:38:21 PM
RXi Pharma (RXII) Granted 180-Day Extension By Nasdaq Stock Market To Regain Compliance With Listing Requirements 8/3/2017 11:02:17 AM
RXi Pharma (RXII) Announces Completion Of Enrollment Of Phase I/II Clinical Trial With RXI-109 For Retinal Scarring 6/21/2017 6:24:40 AM
RXi Pharma (RXII) Announces The Initiation Of Its Consumer Testing Program With RXI-231 6/12/2017 7:41:36 AM
RXi Pharma (RXII) Announces The Appointment Of Dr. Jonathan Freeman To Its Board Of Directors 6/7/2017 10:50:02 AM
RXi Pharma (RXII) To Present At The 3rd Annual Immuno-Oncology BD&L And Investment Forum 5/23/2017 7:47:20 AM
PCI Biotech And RXi Pharma (RXII) Extend Research Collaboration To The Field Of Immuno-Oncology 5/22/2017 9:35:05 AM